Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Diabetes Mellitus, Type 2 × Cholecalciferol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 20 Vitamin D Deficiency 19 Prostatic Neoplasms 14 Polycystic Ovary Syndrome 10 Neoplasms 8 Colonic Neoplasms 8 Rectal Neoplasms 6 Osteoporosis 5 Myelodysplastic Syndromes 5 Colorectal Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Cardiovascular Diseases 4 Warts 3 Ovarian Neoplasms 3 Leukemia, Myeloid, Acute 3 Leukemia 3 Brain Neoplasms 3 Adenomatous Polyps 3 Pathologic Processes 2 Pain 2 Obesity 2 Myeloproliferative Disorders 2 Myelodysplastic-Myeloproliferative Diseases 2 Melanoma 2 Male Urogenital Diseases 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, Follicular 2 Insulin Resistance 2

Interventions

relacorilant 5 Pioglitazone 4 Metformin 4 Sitagliptin Phosphate 3 saxagliptin 2 Vildagliptin 2 Sulfonylurea Compounds 2 Rosiglitazone 2 Resistance Training 2 Nutritional Status 2 Dipeptidyl-Peptidase IV Inhibitors 2 Blood Specimen Collection 2 voglibose 1 somapacitan 1 semaglutide 1 repaglinide 1 pembrolizumab 1 miglitol 1 metahexamide 1 meglitinide 1 mazdutide 1 glymidine 1 glisoxepide 1 gliquidone 1 glimepiride 1 glibornuride 1 dapagliflozin 1 alogliptin 1 Urine Specimen Collection 1 Troglitazone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01463813 2018-10-23

FIND

University of Eastern Finland

Phase NA Completed

Cardiovascular Diseases, Diabetes Mellitus, Type 2, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡